StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis US Real PCE Health Care by Quarter

US Real PCE Health Care (real 2017 USD billions, quarterly) ($M)

Novartis US Real PCE Health Care: $3,858,671M in Q3 2026, up 6.7% from a year earlier. That is the highest of the 43 quarters on record here.

Latest, Q3 2026
3,858,671
Period ended Sep 30, 2026
Change on a year earlier
+6.7%
3,614,854 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA

Where the Q3 2026 figure comes from

Source: Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗

Reported in FRED / BEA (DHLCRC1Q027SBEA, quarterly through FY2026Q3).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUS Real PCE Health Care (real 2017 USD billions, quarterly) ($M)Year on yearSource
Q3 2026Sep 30, 20263,858,671+6.7%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q2 2026Jun 30, 20263,790,292+7.4%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q1 2026Mar 31, 20263,699,899+6.8%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q4 2025Dec 31, 20253,666,986+7.3%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q3 2025Sep 30, 20253,614,854+7.6%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q2 2025Jun 30, 20253,529,833+7.3%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q1 2025Mar 31, 20253,464,650+6.8%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q4 2024Dec 31, 20243,417,834+8.2%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q3 2024Sep 30, 20243,358,244+9.1%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q2 2024Jun 30, 20243,288,215+8.4%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q1 2024Mar 31, 20243,244,355+8.8%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q4 2023Dec 31, 20233,159,378+8.7%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q3 2023Sep 30, 20233,079,031+8.4%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q2 2023Jun 30, 20233,034,799+9.5%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q1 2023Mar 31, 20232,982,530+8.3%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗
Q4 2022Dec 31, 20222,907,037+6.5%Federal Reserve Economic Data (FRED) — Series DHLCRC1Q027SBEA ↗

Cite this data

StockData. (2026). Novartis US Real PCE Health Care ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/ext-fred-pce-healthcare-q

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.